Award recordCONTRACT

UNITED THERAPEUTICS CORP

PIID 36C25019F0609· VHA· 250-NETWORK CONTRACT OFFICE 10 (36C250)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $180,703 net obligations· UEI KK5FBFA43JS7· MD

Description

REMODULIN

First action · last action
2019-01-09 · 2021-01-13
Transactions
4
First transaction's obligation
$195,031
Base + all options value (sum of deltas)
$180,703
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA797P15A0007
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 4 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$195,031$0Base award · 2019-01-09 · this action $195,031 · running total $195,031Modification P00001 · 2019-01-10 · this action $0 · running total $195,031Modification P00002 · 2021-01-05 · this action -$13,686 · running total $181,345Modification P00003 · 2021-01-13 · this action -$642 · running total $180,703
  • Base2019-01-09+$195,031= $195,031
  • Mod P000012019-01-10+$0= $195,031
  • Mod P000022021-01-05-$13,686= $181,345
  • Mod P000032021-01-13-$642= $180,703
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-01-09+$195,031$195,031REMODULIN
Mod P00001· OTHER ADMINISTRATIVE ACTION2019-01-10+$0$195,031REMODULIN
Mod P00002· FUNDING ONLY ACTION2021-01-05−$13,686$181,345REMODULIN
Mod P00003· FUNDING ONLY ACTION2021-01-13−$642$180,703REMODULIN

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI KK5FBFA43JS7)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0777245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$33,158FY2026
36C24526N0755245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0754245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$15,746FY2026
36C24526N0723245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0722245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0707245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026

Other recipients under 6505 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25026P0991ASD SPECIALTY HEALTHCARE, LLC250-NETWORK CONTRACT OFFICE 10 (36C250)$43,680FY2026
36C25026F0668COSETTE PHARMACEUTICALS, INC.250-NETWORK CONTRACT OFFICE 10 (36C250)$10,398FY2026
36C25026N0655PROGENICS PHARMACEUTICALS INC250-NETWORK CONTRACT OFFICE 10 (36C250)$721,744FY2026
36C25026N0616AMERICAN NATIONAL RED CROSS, THE250-NETWORK CONTRACT OFFICE 10 (36C250)$37,180FY2026
36C25026D0061AMERICAN NATIONAL RED CROSS, THE250-NETWORK CONTRACT OFFICE 10 (36C250)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25019F0609_3600_VA797P15A0007_3600 · retrieved 2026-09-26.